We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Acadia Healthcare (ACHC) Beats on Q1 Earnings and Revenues
Read MoreHide Full Article
Acadia Healthcare Company, Inc. (ACHC - Free Report) reported first-quarter 2018 adjusted earnings of 52 cents per share, which beat the Zacks Consensus Estimate by 8.33%. Moreover, earnings improved 13% year over year.
Earnings also flew above the company’s guidance of 47 cents to 49 cents. Better-than-expected earnings were driven by revenue growth led by the addition of beds.
Acadia Healthcare Company, Inc. Price, Consensus and EPS Surprise
Acadia Healthcare’s revenues rose 9.3% to $742 million from the prior-year quarter and surpassed the Zacks Consensus Estimate by 1.89%.
Total same facility revenues grew 5.6% with a 2% increase in patient days and a 3.5% rise in revenues per patient day. The growth can be attributed to the addition of more than 57 new beds to the existing facilities. The company expects to add more than 800 beds to existing and new facilities in 2018.
U.S. same facility revenues were up 6.1% from the year-ago quarter. The company also recorded a 2% increase in patient days year over year, and a 4.0% increase in revenue per patient day.
U.K. same facility revenues rose 4.6% year over year to $236.4 million. The number of patient days inched up 1.9% from the year-ago quarter, and revenue per patient per day was up 2.6%.
Acadia Healthcare’s consolidated adjusted EBITDA was $145.7 million, up 6.9% year over year.
Total expenses increased 10% year over year to $694 million due to higher salaries, professional fees, wages and benefits, supplies as well as rents and leases.
Financial Update
Cash and cash equivalents as of Mar 31, 2018 were $57.8 million, down 14.1% from the 2017-end level.
Long-term debt was $3.21 billion as of Mar 31, 2018, almost unchanged from the 2017-end level.
Net cash provided by operating activities at the end of the first quarter was $72.35 million, up 27% year over year.
2018 Guidance
For 2018, the company expects adjusted earnings per share between $2.58 and $2.62 (versus $2.42 and $2.48 earlier) on revenues of $3.04-$3.08 billion (unchanged). Adjusted EBITDA stayed unchanged and is expected between $637 million and $644 million.
The company projects an exchange rate of $1.35 per British Pound Sterling and a tax rate of about 16% (versus 21% as anticipated earlier).
Zacks Rank and Other Stocks
Acadia Healthcare carries a Zacks Rank #2 (Buy). Among the other firms in the medical sector that have reported first-quarter earnings so far, the bottom line of Anthem Inc. , Aetna Inc. and UnitedHealth Group Inc. (UNH - Free Report) beat their respective Zacks Consensus Estimate. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Acadia Healthcare (ACHC) Beats on Q1 Earnings and Revenues
Acadia Healthcare Company, Inc. (ACHC - Free Report) reported first-quarter 2018 adjusted earnings of 52 cents per share, which beat the Zacks Consensus Estimate by 8.33%. Moreover, earnings improved 13% year over year.
Earnings also flew above the company’s guidance of 47 cents to 49 cents.
Better-than-expected earnings were driven by revenue growth led by the addition of beds.
Acadia Healthcare Company, Inc. Price, Consensus and EPS Surprise
Acadia Healthcare Company, Inc. Price, Consensus and EPS Surprise | Acadia Healthcare Company, Inc. Quote
Quarter Details
Acadia Healthcare’s revenues rose 9.3% to $742 million from the prior-year quarter and surpassed the Zacks Consensus Estimate by 1.89%.
Total same facility revenues grew 5.6% with a 2% increase in patient days and a 3.5% rise in revenues per patient day. The growth can be attributed to the addition of more than 57 new beds to the existing facilities. The company expects to add more than 800 beds to existing and new facilities in 2018.
U.S. same facility revenues were up 6.1% from the year-ago quarter. The company also recorded a 2% increase in patient days year over year, and a 4.0% increase in revenue per patient day.
U.K. same facility revenues rose 4.6% year over year to $236.4 million. The number of patient days inched up 1.9% from the year-ago quarter, and revenue per patient per day was up 2.6%.
Acadia Healthcare’s consolidated adjusted EBITDA was $145.7 million, up 6.9% year over year.
Total expenses increased 10% year over year to $694 million due to higher salaries, professional fees, wages and benefits, supplies as well as rents and leases.
Financial Update
Cash and cash equivalents as of Mar 31, 2018 were $57.8 million, down 14.1% from the 2017-end level.
Long-term debt was $3.21 billion as of Mar 31, 2018, almost unchanged from the 2017-end level.
Net cash provided by operating activities at the end of the first quarter was $72.35 million, up 27% year over year.
2018 Guidance
For 2018, the company expects adjusted earnings per share between $2.58 and $2.62 (versus $2.42 and $2.48 earlier) on revenues of $3.04-$3.08 billion (unchanged). Adjusted EBITDA stayed unchanged and is expected between $637 million and $644 million.
The company projects an exchange rate of $1.35 per British Pound Sterling and a tax rate of about 16% (versus 21% as anticipated earlier).
Zacks Rank and Other Stocks
Acadia Healthcare carries a Zacks Rank #2 (Buy). Among the other firms in the medical sector that have reported first-quarter earnings so far, the bottom line of Anthem Inc. , Aetna Inc. and UnitedHealth Group Inc. (UNH - Free Report) beat their respective Zacks Consensus Estimate. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>